Doherty J. James's most recent trade in Acumen Pharmaceuticals Inc was a trade of 93,300 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Acumen Pharmaceuticals Inc | James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 93,300 | 93,300 | - | - | Employee Stock Option (right to buy) | |
Acumen Pharmaceuticals Inc | James J. Doherty | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 62,600 | 62,600 | - | 0 | Common Stock | |
Acumen Pharmaceuticals Inc | Doherty J. James | President and CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 601,000 | 601,000 | - | - | Employee Stock Option (right to buy) |